The Evolving CAR-T Therapy Supply Chain: Progress and Challenges
Autologous CAR T-cell therapies supply chain: challenges and opportunities? | Cancer Gene Therapy
Manufacturing - CARGO Therapeutics
The Cell Therapy Supply ChainBioProcess International
CAR-T Supply Chain Logistics - Contract Pharma Article
Consideration of a Sustainable Cell and Gene Therapy Ecosystem —The Case of CAR-T Cell Therapy—
Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods - ScienceDirect
Addressing the Challenges of Sample Identification in CAR T Cell Therapy - Labtag Blog
A digital platform for the design of patient-centric supply chains | Scientific Reports
What's the Future of CAR-T Manufacturing? - Blue Matter Consulting
CAR-T Technology and Platform Service | Healthcare+ B2B
Operations: Gateway to Success in Cell and Gene Therapies
Driving the next wave of innovation in CAR T-cell therapies | McKinsey
Advances in CAR-T manufacture – Bridging the commercialization gaps
Can Supply Chain Startups Provide a Digital Prescription for the Red Hot Personalized Autologous CAR-T Industry?
How to choose the best medium for CAR-T manufacturing - RegMedNet
Autologous Cell Therapy Requires Agility in the Cold Chain
Frontiers | Manufacturing and Management of CAR T-Cell Therapy in “COVID-19's Time”: Central Versus Point of Care Proposals
Kite talks audits, training and dry runs across CAR T supply chain
Logistic solutions for CAR T-cell therapy - let's scale!
